Vitiligo, Melasma, PIH, and Albinism: Clinical Update and Emerging Therapies
Dermatology Times,
Pigmentary disorders, though rarely life-threatening, pose a significant therapeutic challenge.
Pigmentary disorders, though rarely life-threatening, pose a significant therapeutic challenge.
ORLANDO — Janus kinase (JAK) inhibitors are emerging as a potential treatment option for alopecia areata, eczema, and vitiligo.